Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


08.03.2021

5 Ann Surg Oncol
4 BMC Cancer
1 Breast Cancer
5 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
9 Breast Cancer Res Treat
2 Breast J
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
3 Cancer Res
2 Clin Breast Cancer
1 Clin Cancer Res
2 Clin Exp Metastasis
1 Eur J Cancer
6 Eur J Surg Oncol
2 Int J Oncol
3 Int J Radiat Oncol Biol Phys
3 J Clin Oncol
6 J Surg Oncol
1 Lancet Oncol
3 Nature
3 NPJ Breast Cancer
4 Oncogene
6 Oncol Rep
1 Oncology
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. DINH KH, Diego EJ
    ASO Author Reflections: Improvement in Postoperative Pain, Nausea, and Vomiting After Implementation of an Enhanced Recovery Protocol for Breast Surgery.
    Ann Surg Oncol. 2020;27.
    PubMed        

  2. LIVINGSTON-ROSANOFF D, Trentham-Dietz A, Hampton JM, Newcomb PA, et al
    Evaluation of Long-Term Satisfaction with Breast Surgery in Patients Treated for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
    Ann Surg Oncol. 2020;27:2628-2636.
    PubMed         Abstract available

  3. PHANTANA-ANGKOOL A, White RL Jr
    ASO Author Reflections: Is Sentinel Lymph Node Biopsy Necessary in Patients with Ductal Carcinoma In Situ with Microinvasion Diagnosed on Core Biopsy?
    Ann Surg Oncol. 2020;27.
    PubMed        

  4. CHANG SB
    ASO Author Reflections: We Can Do It: Using Non-Opioid Regimens After Breast Surgery.
    Ann Surg Oncol. 2020;27.
    PubMed        

  5. RELATION T, Oppong BA
    ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Mar 3. pii: 10.1245/s10434-021-09680.
    PubMed        


    BMC Cancer

  6. MILLS MN, Walker C, Thawani C, Naz A, et al
    Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases.
    BMC Cancer. 2021;21:223.
    PubMed         Abstract available

  7. HUANG Z, Zhou X, Tong Y, Zhu L, et al
    Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
    BMC Cancer. 2021;21:222.
    PubMed         Abstract available

  8. LIU X, Zheng D, Wu Y, Luo C, et al
    Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
    BMC Cancer. 2021;21:226.
    PubMed         Abstract available

  9. OLOW AK, Veer LV', Wolf DM
    Toward developing a metastatic breast cancer treatment strategy that incorporates history of response to previous treatments.
    BMC Cancer. 2021;21:212.
    PubMed         Abstract available


    Breast Cancer

  10. NAHVIJOU A, Safari H, Ameri H
    Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population.
    Breast Cancer. 2021 Mar 5. pii: 10.1007/s12282-021-01230.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  11. MCCART REED AE, Kalaw EM, Lakhani SR
    An Update on the Molecular Pathology of Metaplastic Breast Cancer.
    Breast Cancer (Dove Med Press). 2021;13:161-170.
    PubMed         Abstract available


  12. Erratum: Breast Cancer Screening Practice and Associated Factors Among Women Aged 20-70 Years in Urban Settings of SNNPR, Ethiopia [Corrigendum].
    Breast Cancer (Dove Med Press). 2021;13:133.
    PubMed         Abstract available

  13. YUAN P, Xu B
    Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective.
    Breast Cancer (Dove Med Press). 2021;13:135-150.
    PubMed         Abstract available

  14. GADISA DA, Wang SH, Yimer G
    The Impact of AC and AC-T Chemotherapy's Toxicities on Quality of Life Among Women with Breast Cancer in Ethiopia: A Prospective Patient-Reported Outcomes Study.
    Breast Cancer (Dove Med Press). 2021;13:107-132.
    PubMed         Abstract available

  15. LINEHAN AS, Fitzpatrick OM, Morris PG
    Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review.
    Breast Cancer (Dove Med Press). 2021;13:151-159.
    PubMed         Abstract available


    Breast Cancer Res

  16. PAIRAWAN S, Zhao M, Yuca E, Annis A, et al
    First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models.
    Breast Cancer Res. 2021;23:29.
    PubMed         Abstract available

  17. STRINGER-REASOR EM, May JE, Olariu E, Caterinicchia V, et al
    An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
    Breast Cancer Res. 2021;23:30.
    PubMed         Abstract available


    Breast Cancer Res Treat

  18. KAUFMAN PA, Hurvitz SA, O'Shaughnessy J, Mason G, et al
    Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
    Breast Cancer Res Treat. 2021 Feb 28. pii: 10.1007/s10549-021-06103.
    PubMed         Abstract available

  19. O'SHAUGHNESSY J, Robert N, Annavarapu S, Zhou J, et al
    Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant trastuzumab: a real-world evidence study.
    Breast Cancer Res Treat. 2021 Mar 1. pii: 10.1007/s10549-021-06137.
    PubMed         Abstract available

  20. PARK KU, Gregory M, Bazan J, Lustberg M, et al
    Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.
    Breast Cancer Res Treat. 2021 Mar 2. pii: 10.1007/s10549-021-06153.
    PubMed         Abstract available

  21. SMITH SG, Sestak I, Morris MA, Harvie M, et al
    The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies.
    Breast Cancer Res Treat. 2021 Mar 3. pii: 10.1007/s10549-021-06141.
    PubMed         Abstract available

  22. STRELL C, Stenmark Tullberg A, Jetne Edelmann R, Akslen LA, et al
    Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial.
    Breast Cancer Res Treat. 2021 Mar 4. pii: 10.1007/s10549-021-06136.
    PubMed         Abstract available

  23. ZDRAVKOVIC D, Petricevic S, Toskovic B
    Influence of different response after neoadjuvant chemotherapy on time of surgery in breast cancer patients.
    Breast Cancer Res Treat. 2021 Mar 4. pii: 10.1007/s10549-021-06161.
    PubMed        

  24. TURBOW SD, White MC, Breslau ES, Sabatino SA, et al
    Mammography use and breast cancer incidence among older U.S. women.
    Breast Cancer Res Treat. 2021 Mar 5. pii: 10.1007/s10549-021-06160.
    PubMed         Abstract available

  25. IACUZZO C, Giudici F, Scomersi S, Ceccherini R, et al
    Direct comparison of three different mathematical models in two independent datasets of EUSOMA certified centers to predict recurrence and survival in estrogen receptor-positive breast cancer: impact on clinical practice.
    Breast Cancer Res Treat. 2021 Mar 1. pii: 10.1007/s10549-021-06144.
    PubMed         Abstract available

  26. FALCONE M, Liu L, Farias A, Zhang J, et al
    Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study.
    Breast Cancer Res Treat. 2021 Mar 6. pii: 10.1007/s10549-021-06119.
    PubMed         Abstract available


    Breast J

  27. ROY E, Hall J, Zhu X, Egro FM, et al
    The impact of autologous versus implant-based breast reconstruction on body mass index in breast cancer patients.
    Breast J. 2021 Mar 3. doi: 10.1111/tbj.14214.
    PubMed        

  28. MISHRA S, Handa G
    Role of tranexamic acid in axillary lymph node dissection in breast cancer patients: Does it help in reducing lymphedema?
    Breast J. 2021 Mar 5. doi: 10.1111/tbj.14207.
    PubMed        


    Cancer Epidemiol Biomarkers Prev

  29. KOYRATTY N, McCann SE, Millen AE, Nie J, et al
    Sugar-Sweetened Soda Consumption and Total and Breast Cancer Mortality: The Western New York Exposures and Breast Cancer (WEB) Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Mar 2. pii: 1055-9965.EPI-20-1242.
    PubMed         Abstract available


    Cancer Lett

  30. SONG D, He H, Sinha I, Hases L, et al
    Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.
    Cancer Lett. 2021 Feb 27. pii: S0304-3835(21)00092.
    PubMed         Abstract available


    Cancer Res

  31. HEASTER TM, Humayun M, Yu J, Beebe DJ, et al
    Autofluorescence Imaging of 3D Tumor-Macrophage Microscale Cultures Resolves Spatial and Temporal Dynamics of Macrophage Metabolism.
    Cancer Res. 2020;80:5408-5423.
    PubMed         Abstract available

  32. MIAR A, Arnaiz E, Bridges E, Beedie S, et al
    Hypoxia Induces Transcriptional and Translational Downregulation of the Type I IFN Pathway in Multiple Cancer Cell Types.
    Cancer Res. 2020;80:5245-5256.
    PubMed         Abstract available

  33. LIAPIS E, Klemm U, Karlas A, Reber J, et al
    Resolution of Spatial and Temporal Heterogeneity in Bevacizumab-Treated Breast Tumors by Eigenspectra Multispectral Optoacoustic Tomography.
    Cancer Res. 2020;80:5291-5304.
    PubMed         Abstract available


    Clin Breast Cancer

  34. LIN J, Guo Z, Wang S, Zheng X, et al
    Omission of Chemotherapy in HR+/HER2- Early Invasive Breast Cancer Based on Combined 6-IHC Score?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00023.
    PubMed         Abstract available

  35. ZHAO RP, Li Z, Li C, Xu K, et al
    A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women.
    Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30337.
    PubMed         Abstract available


    Clin Cancer Res

  36. TOLANEY SM, Sahebjam S, Rhun EL, Bachelot T, et al
    Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast Cancer.
    Clin Cancer Res. 2021;27:1582.
    PubMed        


    Clin Exp Metastasis

  37. RASHID NS, Grible JM, Clevenger CV, Harrell JC, et al
    Breast cancer liver metastasis: current and future treatment approaches.
    Clin Exp Metastasis. 2021 Mar 6. pii: 10.1007/s10585-021-10080.
    PubMed         Abstract available

  38. LINDGREN M, Jansson M, Tavelin B, Dirix L, et al
    Type IV collagen as a potential biomarker of metastatic breast cancer.
    Clin Exp Metastasis. 2021 Mar 3. pii: 10.1007/s10585-021-10082.
    PubMed         Abstract available


    Eur J Cancer

  39. PETRELLI F, Parati MC, Borgonovo K, Cabiddu M, et al
    Adjuvant chemotherapy for pT1abN0M0 triple-negative breast cancer: a systematic review and meta-analysis of published studies.
    Eur J Cancer. 2021;147:151-153.
    PubMed        


    Eur J Surg Oncol

  40. LORENZON L, Brandl A, Guiral DC, Hoogwater F, et al
    Nutritional assessment in surgical oncology: An ESSO-EYSAC global survey.
    Eur J Surg Oncol. 2020;46:2074-2082.
    PubMed         Abstract available

  41. NOGUCHI M, Inokuchi M, Noguchi M, Morioka E, et al
    Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
    Eur J Surg Oncol. 2020;46:2218-2220.
    PubMed         Abstract available

  42. BUNDRED J, Michael S, Bowers S, Barnes N, et al
    Do surgical margins matter after mastectomy? A systematic review.
    Eur J Surg Oncol. 2020;46:2185-2194.
    PubMed         Abstract available

  43. JEREMIASSE B, van den Bosch CH, Wijnen MWHA, Terwisscha van Scheltinga CEJ, et al
    Systematic review and meta-analysis concerning near-infrared imaging with fluorescent agents to identify the sentinel lymph node in oncology patients.
    Eur J Surg Oncol. 2020;46:2011-2022.
    PubMed         Abstract available

  44. WANG J, Xiu B, Guo R, Zhang Q, et al
    Autologous tissue reconstruction after mastectomy-A cross-sectional survey of 110 hospitals in China.
    Eur J Surg Oncol. 2020;46:2202-2207.
    PubMed         Abstract available

  45. BRORSON F, Thorarinsson A, Kolby L, Elander A, et al
    Early complications in delayed breast reconstruction: A prospective, randomized study comparing different reconstructive methods in radiated and non-radiated patients.
    Eur J Surg Oncol. 2020;46:2208-2217.
    PubMed         Abstract available


    Int J Oncol

  46. WU D, Jia H, Zhang Z, Li S, et al
    Circ_0000511 accelerates the proliferation, migration and invasion, and restrains the apoptosis of breast cancer cells through the miR326/TAZ axis.
    Int J Oncol. 2021;58:1.
    PubMed         Abstract available

  47. HUERTA-REYES M, Aguilar-Rojas A
    Threedimensional models to study breast cancer (Review).
    Int J Oncol. 2021;58:331-343.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  48. VAIDYA JS, Bulsara M, Sperk E, Massarut S, et al
    TARGIT-IORT during lumpectomy for breast cancer - better for patients than other PBI approaches.
    Int J Radiat Oncol Biol Phys. 2021 Feb 24. pii: S0360-3016(21)00199.
    PubMed        

  49. POLGAR C, Strnad V, Hannoun-Levi JM, Major T, et al
    Reply to the Editor - Do we think seriously that a single shot of 5 Gy intraoperative irradiation at 1 cm is able to avoid any local recurrence or non-breast cancer death after breast-conserving surgery?
    Int J Radiat Oncol Biol Phys. 2021 Feb 24. pii: S0360-3016(21)00198.
    PubMed        

  50. CHANG WI, Han MG, Kang MH, Park JM, et al
    PI3Kalphadelta Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model.
    Int J Radiat Oncol Biol Phys. 2021 Feb 25. pii: S0360-3016(21)00085.
    PubMed         Abstract available


    J Clin Oncol

  51. BUCHHOLZ TA, Ali S, Hunt KK
    Reply to A. Thomsen et al.
    J Clin Oncol. 2020;38:3577.
    PubMed        

  52. DALLA VOLTA A, Mazziotti G, Maffezzoni F, Grisanti S, et al
    Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies.
    J Clin Oncol. 2020;38:3363-3366.
    PubMed        

  53. RECHT A
    Hypofractionated Whole-Breast Irradiation: Case Closed?
    J Clin Oncol. 2020;38:3584-3586.
    PubMed        


    J Surg Oncol

  54. LEE J, Park HS, Lee H, Lee K, et al
    Axillary lymph node dissection using a robotic surgical system: Initial experience.
    J Surg Oncol. 2020;122:1252-1256.
    PubMed        

  55. BROYLES JM, Smith JM, Phillips BT, Mericli AF, et al
    The effect of sarcopenia on perioperative complications in abdominally based free-flap breast reconstruction.
    J Surg Oncol. 2020;122:1240-1246.
    PubMed         Abstract available

  56. JACKSON DK, Li Y, Eskander MF, Tsung A, et al
    Racial disparities in low-value surgical care and time to surgery in high-volume hospitals.
    J Surg Oncol. 2021;123:676-686.
    PubMed         Abstract available

  57. ARCIERO CA, Diehl AH 3rd, Liu Y, Sun Q, et al
    Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers.
    J Surg Oncol. 2020;122:1232-1239.
    PubMed         Abstract available

  58. MELE A, Fan B, Pardo J, Emhoff I, et al
    Axillary lymph node dissection in the era of immediate lymphatic reconstruction: Considerations for the breast surgeon.
    J Surg Oncol. 2021;123:842-845.
    PubMed        

  59. WOESTE MR, Bhutiani N, Donaldson M, McMasters KM, et al
    Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
    J Surg Oncol. 2021;123:439-445.
    PubMed         Abstract available


    Lancet Oncol

  60. CARRASCOSA MF, Fernandez-Ayala M, Cano Hoz M, Abascal Carrera I, et al
    Pathological fracture from clinically occult breast cancer.
    Lancet Oncol. 2021;22:e131.
    PubMed        


    Nature

  61. MA S, Wu Z, Yang F, Zhang J, et al
    Hippo signalling maintains ER expression and ER(+) breast cancer growth.
    Nature. 2021;591:E1-E10.
    PubMed        

  62. BRITSCHGI A, Couto JP, Bentires-Alj M
    Reply to: Hippo signalling maintains ER expression and ER(+) breast cancer growth.
    Nature. 2021;591:E11-E12.
    PubMed        

  63. JIN X, Demere Z, Nair K, Ali A, et al
    A metastasis map of human cancer cell lines.
    Nature. 2020;588:331-336.
    PubMed         Abstract available


    NPJ Breast Cancer

  64. BECA F, Oh H, Collins LC, Tamimi RM, et al
    The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease.
    NPJ Breast Cancer. 2021;7:23.
    PubMed         Abstract available

  65. MAKOWER D, Lin J, Xue X, Sparano JA, et al
    Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer.
    NPJ Breast Cancer. 2021;7:20.
    PubMed         Abstract available

  66. DRAGANOV D, Han Z, Rana A, Bennett N, et al
    Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer.
    NPJ Breast Cancer. 2021;7:22.
    PubMed         Abstract available


    Oncogene

  67. JALALIRAD M, Haddad TC, Salisbury JL, Radisky D, et al
    Aurora-A kinase oncogenic signaling mediates TGF-beta-induced triple-negative breast cancer plasticity and chemoresistance.
    Oncogene. 2021 Mar 5. pii: 10.1038/s41388-021-01711.
    PubMed         Abstract available

  68. REINSBOROUGH CW, Ipas H, Abell NS, Gouws EB, et al
    BCDIN3D RNA methyltransferase stimulates Aldolase C expression and glycolysis through let-7 microRNA in breast cancer cells.
    Oncogene. 2021 Mar 4. pii: 10.1038/s41388-021-01702.
    PubMed         Abstract available

  69. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-020-01620.
    PubMed        

  70. GE LP, Jin X, Yang YS, Liu XY, et al
    Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-021-01655.
    PubMed         Abstract available


    Oncol Rep

  71. AN SQ, He K, Liu F, Ding QS, et al
    Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer.
    Oncol Rep. 2021;45:1235-1248.
    PubMed         Abstract available

  72. XU X, Liu M, Yang Y, Wei C, et al
    VSP17 suppresses the migration and invasion of triplenegative breast cancer cells through inhibition of the EMT process via the PPARgamma/AMPK signaling pathway.
    Oncol Rep. 2021;45:975-986.
    PubMed         Abstract available

  73. CHEN H, Sun Y, Yang Z, Yin S, et al
    Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review).
    Oncol Rep. 2021;45:846-856.
    PubMed         Abstract available

  74. NAKANISHI M, Korechika A, Yamakawa H, Kawabe N, et al
    Acidic microenvironment induction of interleukin-8 expression and matrix metalloproteinase-2/-9 activation via acid-sensing ion channel 1 promotes breast cancer cell progression.
    Oncol Rep. 2021;45:1284-1294.
    PubMed         Abstract available

  75. ZHUANG Y, Li X, Zhan P, Pi G, et al
    MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein.
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available

  76. GUO Q, Liu Y, He Y, Du Y, et al
    CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.
    Oncol Rep. 2021;45:1.
    PubMed         Abstract available


    Oncology

  77. ZIMMERMAN BS, Seidman D, Cascetta KP, Ru M, et al
    Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
    Oncology. 2021 Mar 2:1-12. doi: 10.1159/000512212.
    PubMed         Abstract available


    PLoS One

  78. LUO HB, Liu YY, Wang CH, Qing HM, et al
    Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.
    PLoS One. 2021;16:e0247074.
    PubMed         Abstract available

  79. AL-SALEH K, Salah T, Arafah M, Husain S, et al
    Prognostic significance of estrogen, progesterone and HER2 receptors' status conversion following neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from a tertiary Cancer Center in Saudi Arabia.
    PLoS One. 2021;16:e0247802.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  80. WOLFSBERGER J, Sakil HAM, Zhou L, van Bree N, et al
    TAp73 represses NF-kappaB-mediated recruitment of tumor-associated macrophages in breast cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Radiology

  81. DUFFY SW, Tabar L, Yen AM, Dean PB, et al
    Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.
    Radiology. 2021 Mar 2:203935. doi: 10.1148/radiol.2021203935.
    PubMed         Abstract available


    Radiother Oncol

  82. KIM N, Kim H, Hwang JH, Park W, et al
    Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: an analysis of serial changes in arm volume measured by infrared optoelectronic volumetry.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06096.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: